RESUMEN
With the aim of identifying novel neonicotinoid insecticides with low bee toxicity, a series of compounds bearing thiazolidine moiety, which has been shown to be low bee toxic, were rationally designed through substructure splicing strategy and evaluated insecticidal activities. The optimal compounds A24 and A29 exhibited LC50 values of 30.01 and 17.08 mg/L against Aphis craccivora, respectively. Electrophysiological studies performed on Xenopus oocytes indicated that compound A29 acted on insect nAChR, with EC50 value of 50.11 µM. Docking binding mode analysis demonstrated that A29 bound to Lymnaea stagnalis acetylcholine binding protein through H-bonds with the residues of D_Arg55, D_Leu102, and D_Val114. Quantum mechanics calculation showed that A29 had a higher highest occupied molecular orbit (HOMO) energy and lower vertical ionization potential (IP) value compared to the high bee toxic imidacloprid, showing potentially low bee toxicity. Bee toxicity predictive model also indicated that A29 was nontoxic to honeybees. Our present work identified an innovative insecticidal scaffold and might facilitate the further exploration of low bee toxic neonicotinoid insecticides.
Asunto(s)
Insecticidas , Neonicotinoides , Tiazolidinas , Animales , Insecticidas/química , Insecticidas/toxicidad , Abejas/efectos de los fármacos , Neonicotinoides/química , Neonicotinoides/toxicidad , Tiazolidinas/química , Tiazolidinas/toxicidad , Simulación del Acoplamiento Molecular , Proteínas de Insectos/genética , Proteínas de Insectos/química , Proteínas de Insectos/metabolismo , Proteínas de Insectos/toxicidad , Áfidos/efectos de los fármacos , Áfidos/genética , Relación Estructura-Actividad , Estructura Molecular , Receptores Nicotínicos/genética , Receptores Nicotínicos/metabolismo , Receptores Nicotínicos/químicaRESUMEN
The effects of hexythiazox on life-history traits and demographic parameters of Tetranychus urticae Koch (Acari: Tetranychidae) were evaluated using the age-stage two-sex life table (in fecundity-based and fertility-based variants), with emphasis on its transovarial toxicity. Hexythiazox was applied when T. urticae females were either in the preovipositional period or in the first day of oviposition. In the F0 generation bioassay, treatments with concentrations of 50, 12.5 and 3.125 mg/l significantly reduced the longevity of females and their fecundity. These effects were mostly the result of mortality of treated females (18-23%) over the 24-h exposure period. Even though the net reproductive rate (R0) decreased significantly, the intrinsic rate of increase (r), finite rate of increase (λ) and doubling time (D) were not significantly different from the control. The strongest transovarial toxic effect occurred within the first 4 days following treatment, when 52-89% of the eggs laid by treated females (96% in control) hatched. Fertility was significantly reduced by concentrations of 50, 12.5, 3.125, 0.781 and 0.195 mg/l. These concentrations caused significant reductions in R0 (34-54%), r (12-24%) and λ (3-5%), whereas D was extended for 0.4-0.7 days. In the F1 generation bioassay, 50, 12.5, 3.125, 0.781, 0.049 and 0.012 mg/l caused significant reductions in R0 (34-92%), r (10-68%) and λ (3-17%), whereas extending D for 0.3-5.6 days. These effects were mostly the consequence of transovarial toxicity. Application of the fecundity-based life table underestimated population-level effects of hexythiazox on T. urticae.
Asunto(s)
Tetranychidae , Tiazolidinas , Animales , Femenino , Tablas de Vida , Oviposición/efectos de los fármacos , Reproducción/efectos de los fármacos , Tetranychidae/efectos de los fármacos , Tiazolidinas/toxicidadRESUMEN
Neglected diseases, such as Leishmaniasis, constitute a group of communicable diseases that occur mainly in tropical countries. Considered a public health problem with limited treatment. Therefore, there is a need for new therapies. In this sense, our proposal was to evaluate in vitro two series of thiazolidine compounds (7a-7e and 8a-8e) against Leishmania infantum. We performed in vitro evaluations through macrophage cytotoxicity assays (J774) and nitric oxide production, activity against promastigotes and amastigotes, as well as ultrastructural analyzes in promastigotes. In the evaluation of cytotoxicity, the thiazolidine compounds presented CC50 values between 8.52 and 126.83 µM. Regarding the evaluation against the promastigote forms, the IC50 values ranged between 0.42 and 142.43 µM. Compound 7a was the most promising, as it had the lowest IC50. The parasites treated with compound 7a showed several changes, such as cell body shrinkage, shortening and loss of the flagellum, intense mitochondrial edema and cytoplasmic vacuolization, leading the parasite to cell inviability. In assays against the amastigote forms, the compound showed a low IC50 (0.65 µM). These results indicate that compound 7a was efficient for both evolutionary forms of the parasite. In silico studies suggest that the compound has good oral bioavailability. These results show that compound 7a is a potential drug candidate for the treatment of Leishmaniasis.
Asunto(s)
Antiprotozoarios , Leishmania infantum , Leishmaniasis , Antiprotozoarios/química , Antiprotozoarios/toxicidad , Humanos , Leishmaniasis/tratamiento farmacológico , Macrófagos/parasitología , Tiazolidinas/toxicidadRESUMEN
Tumor necrosis factor-related apoptosis-induced ligand (TRAIL) is a cytokine that initiates apoptosis upon binding to death receptor 5 (DR5) on cancer cells. Small molecule TRAIL mimetics have therefore been investigated as promising chemotherapeutic agents. Since anemia of chemotherapy is common, our goal is to investigate the hemolytic and eryptotic properties of novel DR5 agonist bioymifi (BMF) and identify the underlying molecular mechanisms. Whole blood (WB) was stimulated with 100 µM of BMF, whereas red blood cells (RBCs) were treated with 10-100 µM of BMF for 24 h at 37 °C. WB was analyzed for RBC, leukocyte, and platelet indices, while RBCs were examined for hemolysis by light absorbance of free hemoglobin, membrane scrambling by Annexin V-FITC, calcium by Fluo4/AM, cellular morphology by light scatter, and oxidative stress by 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) using flow cytometry. Caspase inhibitor Z-VAD-FMK, p38 inhibitor SB203580, casein kinase 1α inhibitor D4476, receptor-interacting protein 1 inhibitor necrostatin-2, reduced glutathione, or cyclooxygenase (COX) inhibitor aspirin were added accordingly. BMF exerted dose-responsive, calcium-independent hemolysis, reduced RBC hemoglobin, significantly increased Annexin V-, Fluo4-, and DCF-positive cells, along with a dual effect on forward and side light scatter. Notably, the cytotoxic potential of BMF was significantly mitigated upon pharmacological inhibition of p38. Furthermore, BMF exhibited selective toxicity to eosinophils and significantly diminished reticulocyte hemoglobin content. Altogether, these novel findings highlight the adverse outcomes of BMF exposure on RBC physiology and provide the first toxicological assessment of BMF as an antitumor agent.
Asunto(s)
Eriptosis/efectos de los fármacos , Ftalimidas/toxicidad , Receptores del Ligando Inductor de Apoptosis Relacionado con TNF/agonistas , Tiazolidinas/toxicidad , Calcio/metabolismo , Eosinófilos/efectos de los fármacos , Eritrocitos/efectos de los fármacos , Hemólisis/efectos de los fármacos , Humanos , Especies Reactivas de Oxígeno/metabolismo , Proteínas Quinasas p38 Activadas por Mitógenos/fisiologíaRESUMEN
BACKGROUND: Aryl-propionic acid derivatives with ibuprofen as representative drug are very important for therapy, being recommended especially for anti-inflammatory and analgesic effects. On other hand 1,3-thiazolidine-4-one scaffold is an important heterocycle, which is associated with different biological effects such as anti-inflammatory and analgesic, antioxidant, antiviral, antiproliferative, antimicrobial etc. The present study aimed to evaluated the toxicity degree and the anti-inflammatory and analgesic effects of new 1,3-thiazolidine-4-one derivatives of ibuprofen. METHODS: For evaluation the toxicity degree, cell viability assay using MTT method and acute toxicity assay on rats were applied. The carrageenan-induced paw-edema in rat was used for evaluation of the anti-inflammatory effect while for analgesic effect the tail-flick test, as thermal nociception in rats and the writhing assay, as visceral pain in mice, were used. RESULTS: The toxicological screening, in terms of cytotoxicity and toxicity degree on mice, revealed that the ibuprofen derivatives (4a-n) are non-cytotoxic at 2 µg/ml. In addition, ibuprofen derivatives reduced carrageenan-induced paw edema in rats, for most of them the maximum effect was recorded at 4 h after administration which means they have medium action latency, similar to that of ibuprofen. Moreover, for compound 4d the effect was higher than that of ibuprofen, even after 24 h of administration. The analgesic effect evaluation highlighted that 4 h showed increased pain inhibition in reference to ibuprofen in thermal (tail-flick assay) and visceral (writhing assay) nociception models. CONCLUSIONS: The study revealed for ibuprofen derivatives, noted as 4 m, 4 k, 4e, 4d, a good anti-inflammatory and analgesic effect and also a safer profile compared with ibuprofen. These findings could suggest the promising potential use of them in the treatment of inflammatory pain conditions.
Asunto(s)
Analgésicos , Antiinflamatorios no Esteroideos , Edema/tratamiento farmacológico , Ibuprofeno , Dolor/tratamiento farmacológico , Tiazolidinas , Ácido Acético , Analgésicos/uso terapéutico , Analgésicos/toxicidad , Animales , Antiinflamatorios no Esteroideos/uso terapéutico , Antiinflamatorios no Esteroideos/toxicidad , Carragenina , Supervivencia Celular/efectos de los fármacos , Edema/inducido químicamente , Calor/efectos adversos , Ibuprofeno/análogos & derivados , Ibuprofeno/uso terapéutico , Ibuprofeno/toxicidad , Dosificación Letal Mediana , Ratones , Dolor/inducido químicamente , Ratas Wistar , Tiazolidinas/uso terapéutico , Tiazolidinas/toxicidadRESUMEN
The compounds from eight different thiazolidine and thiazole series were assessed as potential antileishmanial scaffolds. They were tested for antileishmanial activity against promastigotes of Leishmania major using in vitro primary screen and dose response assays. The compounds from six thiazolidine and thiazole series were identified as the hits with antileishmanial activity against L. major. However, the analyses of structure-activity relations (SARs) showed that the interpretable SARs were obtained only for phenyl-indole hybrids (compounds C1, C2, C3 and C5) as the most effective compounds against L. major promastigotes (IC50 < 10 µM) with low toxicity to human fibroblasts. For the scaffold of these compounds, the most significant SAR patterns were: free N3 position of thiazolidinone core, absence of big fragments at the C5 position of thiazolidinone core and presence of halogen atoms or nitro group in the phenyl ring of phenyl-indole fragment. As previous studies showed that these compounds also have activity against the two Trypanosoma species, Trypanosoma brucei and Trypanosoma gambiense, their scaffold could be associated with a broader antiparasitic activity.
Asunto(s)
Tiazolidinas/farmacología , Tripanocidas/farmacología , Fibroblastos/efectos de los fármacos , Humanos , Leishmania major/efectos de los fármacos , Estructura Molecular , Pruebas de Sensibilidad Parasitaria , Bibliotecas de Moléculas Pequeñas/química , Bibliotecas de Moléculas Pequeñas/farmacología , Bibliotecas de Moléculas Pequeñas/toxicidad , Relación Estructura-Actividad , Tiazolidinas/química , Tiazolidinas/toxicidad , Tripanocidas/química , Tripanocidas/toxicidad , Trypanosoma brucei brucei/efectos de los fármacos , Trypanosoma brucei gambiense/efectos de los fármacosRESUMEN
Metronidazole and its derivatives are widely used for the treatment of amoebiasis. However, metronidazole is considered as the standard drug but it has many side effects. The present study describes the synthesis of a series of metronidazole based thiazolidinone analogs via Knoevenagel condensation of 4-[2-(2-methyl-5-nitro-1H-imidazole-1-yl)ethoxy]benzaldehyde 1 with various thiazolidinone derivatives 2-14 to get the new scaffold (15-27) having better activity and lesser toxicity. Six compounds have shown better efficacy and lesser cytotoxicity than the standard drug metronidazole towards HM1: IMSS strain of Entamoeba histolytica. These compounds may combat the problem of drug resistance and might be effective in identifying potential alternatives for future drug discovery against EhOASS.
Asunto(s)
Amebicidas/farmacología , Metronidazol/farmacología , Tiazolidinas/farmacología , Amebicidas/síntesis química , Amebicidas/metabolismo , Amebicidas/toxicidad , Dominio Catalítico , Entamoeba histolytica/efectos de los fármacos , Células HEK293 , Humanos , Metronidazol/síntesis química , Metronidazol/metabolismo , Metronidazol/toxicidad , Simulación del Acoplamiento Molecular , Estructura Molecular , Pruebas de Sensibilidad Parasitaria , Unión Proteica , Proteínas Protozoarias/química , Proteínas Protozoarias/metabolismo , Relación Estructura-Actividad Cuantitativa , Sulfatasas/química , Sulfatasas/metabolismo , Tiazolidinas/síntesis química , Tiazolidinas/metabolismo , Tiazolidinas/toxicidadRESUMEN
Fosthiazate is a widely used chiral organophosphorous nematicide with four stereoisomers. The present study systemically assessed the stereoselectivity of fosthiazate for the first time, including absolute configuration confirmation, stereoselective bioactivity toward nematode and aphid, toxicity to honeybees, and stereoselective degradation in cucumber and pepper under field conditions. The absolute configurations of the four stereoisomers that eluted on the Superchiral IG-3 column were confirmed as (1S,3R)-(-)-fosthiazate, (1S,3S)-(-)-fosthiazate, (1R,3S)-(+)-fosthiazate, and (1R,3R)-(+)-fosthiazate. In comparison to the other two stereoisomers, (1S,3R)-fosthiazate and (1S,3S)-fosthiazate possess more than 100 times bioactivity and 10 times toxicity toward the target and non-target organisms, respectively. The molecular docking found that (1S,3R)-fosthiazate and (1S,3S)-fosthiazate had shorter binding distances and lower energies with acetylcholinesterase (AChE), which illuminated the mechanism of the experimental results. In addition, both of the high-bioactive stereoisomers had faster degradation rates in cucumber and pepper. On the basis of the results of bioactivity, toxicity, and degradation behavior, the stereoisomer mixture with (1S,3R)-fosthiazate and (1S,3S)-fosthiazate will be a better option than racemic fosthiazate to increase the bioactivity and reduce application rates.
Asunto(s)
Compuestos Organofosforados/química , Plaguicidas/química , Tiazolidinas/química , Verduras/química , Animales , Áfidos/efectos de los fármacos , Abejas/efectos de los fármacos , Capsicum/química , Cucumis sativus/química , Contaminación de Alimentos/análisis , Cinética , Simulación del Acoplamiento Molecular , Compuestos Organofosforados/toxicidad , Plaguicidas/toxicidad , Estereoisomerismo , Tiazolidinas/toxicidadRESUMEN
Stomatal movement, which regulates gas exchange in plants, is controlled by a variety of environmental factors, including biotic and abiotic stresses. The stress hormone abscisic acid (ABA) initiates a signaling cascade, which leads to increased H2O2 and Ca2+ levels and F-actin reorganization, but the mechanism of, and connection between, these events is unclear. SINE1, an outer nuclear envelope component of a plant Linker of Nucleoskeleton and Cytoskeleton complex, associates with F-actin and is, along with its putative paralog SINE2, expressed in guard cells. Here, we have determined that Arabidopsis (Arabidopsis thaliana) SINE1 and SINE2 play an important role in stomatal opening and closing. Loss of SINE1 or SINE2 results in ABA hyposensitivity and impaired stomatal dynamics but does not affect stomatal closure induced by the bacterial elicitor flg22. The ABA-induced stomatal closure phenotype is, in part, attributed to impairments in Ca2+ and F-actin regulation. Together, the data suggest that SINE1 and SINE2 act downstream of ABA but upstream of Ca2+ and F-actin. While there is a large degree of functional overlap between the two proteins, there are also critical differences. Our study makes an unanticipated connection between stomatal regulation and nuclear envelope-associated proteins, and adds two new players to the increasingly complex system of guard cell regulation.
Asunto(s)
Ácido Abscísico/farmacología , Proteínas de Arabidopsis/metabolismo , Arabidopsis/metabolismo , Estomas de Plantas/metabolismo , Transducción de Señal/genética , Ácido Abscísico/metabolismo , Citoesqueleto de Actina/efectos de los fármacos , Citoesqueleto de Actina/metabolismo , Actinas/metabolismo , Arabidopsis/efectos de los fármacos , Arabidopsis/genética , Arabidopsis/fisiología , Proteínas de Arabidopsis/genética , Compuestos Bicíclicos Heterocíclicos con Puentes/toxicidad , Calcio/metabolismo , Cloruro de Calcio/farmacología , Sequías , Peróxido de Hidrógeno/toxicidad , Microscopía Confocal , Mutación , Hojas de la Planta/genética , Hojas de la Planta/metabolismo , Hojas de la Planta/fisiología , Estomas de Plantas/efectos de los fármacos , Estomas de Plantas/genética , Estomas de Plantas/efectos de la radiación , Especies Reactivas de Oxígeno/metabolismo , Transducción de Señal/efectos de los fármacos , Estrés Fisiológico/efectos de los fármacos , Estrés Fisiológico/genética , Tiazolidinas/toxicidad , Regulación hacia ArribaRESUMEN
Different compounds have been investigated as potent drugs for trypanosomiasis treatment, but no new drug has been marketed in the past 3 decades. 4-Thiazolidinone/thiazole as privileged structures and thiosemicarbazides cyclic analogs are well known scaffolds in novel antitrypanosomal agent design. We present here the design and synthesis of new hybrid molecules bearing thiazolidinone/thiazole cores linked by the hydrazone group with various molecular fragments. Structure optimization led to compounds with phenyl-indole or phenyl-imidazo[2,1-b][1,3,4]thiadiazole moieties showing excellent antitrypanosomal activity towards Trypanosoma brucei brucei and Trypanosoma brucei gambiense. Biological study allowed identifying compounds with the submicromolar levels of IC50, good selectivity indexes and relatively low cytotoxicity upon human primary fibroblasts as well as low acute toxicity.
Asunto(s)
Tiazolidinas/farmacología , Tripanocidas/farmacología , Animales , Línea Celular , Humanos , Concentración 50 Inhibidora , Masculino , Ratones , Estructura Molecular , Relación Estructura-Actividad , Tiazolidinas/síntesis química , Tiazolidinas/química , Tiazolidinas/toxicidad , Tripanocidas/síntesis química , Tripanocidas/química , Tripanocidas/toxicidad , Trypanosoma brucei brucei/efectos de los fármacos , Trypanosoma brucei gambiense/efectos de los fármacosRESUMEN
Among gliomas types, glioblastoma is considered the most malignant and the worst form of primary brain tumor. It is characterized by high infiltration rate and great angiogenic capacity. The presence of an inflammatory microenvironment contributes to chemo/radioresistance, resulting in poor prognosis for patients. Recent data show that thiazolidinones have a wide range of pharmacological properties, including anti-inflammatory and antiglioma activities. Nanocapsules of biodegradable polymers become an alternative to cancer treatment since they provide targeted drug delivery and could overcome blood-brain barrier. Therefore, here we investigated the in vitro antiglioma activity and the potential in vivo toxicity of 2- (2-methoxyphenyl) -3- ((piperidin-1-yl) ethyl) thiazolidin-4-one-loaded polymeric nanocapsules (4L-N). Nanocapsules were prepared and characterized in terms of particle size, polydispersity index, zeta potential, pH, molecule content and encapsulation efficiency. Treatment with 4L-N selectively decreased human U138MG and rat C6 cell lines viability and proliferation, being even more efficient than the free-form molecule (4L). In addition, 4L-N did not promote toxicity to primary astrocytes. We further demonstrated that the treatment with sub-therapeutic dose of 4L-N did not alter weight, neither resulted in mortality, toxicity or peripheral damage to Wistar rats. Finally, 4L as well as 4L-N did not alter makers of oxidative damage, such as TBARS levels and total sulfhydryl content, and did not change antioxidant enzymes SOD and CAT activity in liver and brain of treated rats. Taken together, these data indicate that the nanoencapsulation of 4L has potentiated its antiglioma effect and does not cause in vivo toxicity.
Asunto(s)
Neoplasias Encefálicas/tratamiento farmacológico , Glioma/tratamiento farmacológico , Nanocápsulas/química , Piperidinas/toxicidad , Piperidinas/uso terapéutico , Polímeros/química , Tiazolidinas/toxicidad , Tiazolidinas/uso terapéutico , Animales , Apoptosis/efectos de los fármacos , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Astrocitos/patología , Biomarcadores de Tumor/sangre , Encéfalo/efectos de los fármacos , Encéfalo/patología , Neoplasias Encefálicas/sangre , Neoplasias Encefálicas/patología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Liberación de Fármacos , Glioma/sangre , Glioma/patología , Humanos , Luz , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Estrés Oxidativo/efectos de los fármacos , Piperidinas/síntesis química , Piperidinas/química , Polímeros/síntesis química , Ratas Wistar , Tiazolidinas/síntesis química , Tiazolidinas/química , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Pruebas de Toxicidad , Pérdida de Peso/efectos de los fármacosRESUMEN
2-Mercaptothiazoline (MTZ) is broadly present in daily use as an antifungal reagent, a brightening agent, and a corrosion inhibitor. MTZ is potentially harmful for human health. Although the toxic effects of MTZ on experimental animals have been reported, the effects of MTZ on the proteins in the circulatory system at the molecular level have not been identified previously. Here, we explored the interaction of MTZ with bovine hemoglobin (BHb) in vitro using multiple spectroscopic techniques and molecular docking. In this study, the binding capacity, acting force, binding sites, molecular docking simulation, and conformational changes were investigated. MTZ quenched the intrinsic emission of BHb via the static quenching process and could spontaneously bind with BHb mainly through van der Waals forces and hydrogen bond. The computational docking visualized that MTZ bound to the ß2 subunit of BHb, which further led to some changes of the skeleton and secondary structure of BHb. This research provides valuable information about the molecular mechanisms on BHb induced by MTZ and is beneficial for clarifying the toxicological actions of MTZ in blood.
Asunto(s)
Contaminantes Ambientales/metabolismo , Hemoglobinas/metabolismo , Unión Proteica , Tiazolidinas/metabolismo , Animales , Antifúngicos/metabolismo , Antifúngicos/toxicidad , Sitios de Unión , Bovinos , Dicroismo Circular , Contaminantes Ambientales/toxicidad , Enlace de Hidrógeno , Simulación del Acoplamiento Molecular , Subunidades de Proteína , Albúmina Sérica Bovina , Espectrometría de Fluorescencia , Espectrofotometría Ultravioleta , Análisis Espectral , Termodinámica , Tiazolidinas/toxicidadRESUMEN
In the present study, the molecular docking mechanism based on pharmacodynamic interactions between the ligands AZD1208 and recognized chemotherapy agents (Vincristine and Daunorubicin) with human ATP-binding cassette (ABC) transporters (ABCB1) was investigated. For the first time, were combined an in silico approaches like molecular docking and ab initio computational simulation based on Density Functional Theory (DFT) to explain the drug-drug interaction mechanism of aforementioned chemotherapy ligands with the transmembrane ligand extrusion binding domains (TMDs) of ABCB1. In this regard, the theoretical pharmacodynamic interactions were characterized by using the Gibbs free energy (FEB, kcal/mol) from the best ABCB1-ligand docking complexes. The molecular docking results pointing that for the three chemotherapy ABCB1-ligand complexes are mainly based in non-covalent hydrophobic and hydrogen-bond interactions showing a similar toxicodynamic behavior in terms of strength of interaction (FEB, kcal/mol) and very close free binding energies when compared with the FEB-values of the ABCB1 specific-inhibitor (Rhodamine B) = -6.0 kcal/mol used as theoretical docking control to compare with FEB (AZD1208-ABCB1) â¼ FEB (Vincristine-ABCB1) â¼ FEB (Daunorubicin-ABCB1) -6.2 kcal/mol as average. Ramachandran plot suggests that the 3D-crystallographic structure from ABCB1 transporter can be efficiently-modeled with conformationally-favored Psi versus Phi dihedral angles for all key TMDs-residues. Though, the results of DFT-simulation corroborate the existence of drug-drug interaction between (AZD1208/Vincristine) > (AZD1208/Daunorubicin). These theoretical pieces of evidence have preclinical relevance potential in the design of the new drugs to understand the polypharmacology influence in the molecular mechanism of multiple-drugs resistance, contributing with a higher success in chemotherapy and prognosis of cancer patients.
Asunto(s)
Antibióticos Antineoplásicos/toxicidad , Antineoplásicos Fitogénicos/toxicidad , Compuestos de Bifenilo/toxicidad , Daunorrubicina/toxicidad , Inhibidores de Proteínas Quinasas/toxicidad , Transporte de Proteínas/efectos de los fármacos , Tiazolidinas/toxicidad , Vincristina/toxicidad , Subfamilia B de Transportador de Casetes de Unión a ATP/antagonistas & inhibidores , Subfamilia B de Transportador de Casetes de Unión a ATP/efectos de los fármacos , Sitios de Unión/efectos de los fármacos , Línea Celular Tumoral , Teoría Funcional de la Densidad , Interacciones Farmacológicas , Humanos , Ligandos , Conformación Molecular , Simulación del Acoplamiento MolecularRESUMEN
Targeting secreted aspartic protease 2 (SAP2), a kind of virulence factor, represents a new strategy for antifungal drug discovery. In this report, the first-generation of small molecule SAP2 inhibitors was rationally designed and optimized using a structure-based approach. In particular, inhibitor 23h was highly potent and selective and showed good antifungal potency for the treatment of resistant Candida albicans infections.
Asunto(s)
Antifúngicos/uso terapéutico , Proteasas de Ácido Aspártico/antagonistas & inhibidores , Candidiasis/tratamiento farmacológico , Proteínas Fúngicas/antagonistas & inhibidores , Inhibidores de Proteasas/uso terapéutico , Tiazolidinas/uso terapéutico , Animales , Antifúngicos/síntesis química , Antifúngicos/química , Antifúngicos/toxicidad , Proteasas de Ácido Aspártico/química , Caenorhabditis elegans , Candida albicans/efectos de los fármacos , Femenino , Proteínas Fúngicas/química , Humanos , Ratones Endogámicos ICR , Simulación del Acoplamiento Molecular , Inhibidores de Proteasas/síntesis química , Inhibidores de Proteasas/química , Inhibidores de Proteasas/toxicidad , Relación Estructura-Actividad , Tiazolidinas/síntesis química , Tiazolidinas/química , Tiazolidinas/toxicidad , Factores de Virulencia/antagonistas & inhibidores , Factores de Virulencia/químicaAsunto(s)
Antimaláricos/farmacología , Plasmodium berghei/efectos de los fármacos , Plasmodium falciparum/efectos de los fármacos , Quinolinas/química , Tiazolidinas/química , Animales , Antimaláricos/síntesis química , Antimaláricos/química , Antimaláricos/toxicidad , Cloroquina/farmacología , Resistencia a Medicamentos , Eritrocitos/parasitología , Malaria/tratamiento farmacológico , Ratones , Relación Estructura-Actividad , Tiazolidinas/síntesis química , Tiazolidinas/farmacología , Tiazolidinas/toxicidadRESUMEN
Epalrestat (EPS), an aldose reductase inhibitor, is widely prescribed to manage diabetic neuropathy. It is generally believed that EPS is beneficial to diabetic patients because it can protect endothelial cells, Schwann cells, or other neural cells from oxidative stress. However, several clinical studies revealed that EPS therapy led to liver dysfunction, which limited its clinical applications. Currently, the underlying mechanism by which EPS causes liver dysfunction is unknown. This study aimed to investigate the mechanism responsible for EPS-induced liver injury. In mouse liver, EPS 1) increased oxidative stress, indicated by increased expression of manganese superoxide dismutase, Ho-1, and Nqo1, 2) induced inflammation, indicated by infiltration of inflammatory cells, and induced expression of tumor necrosis factor-alpha, CD11b, and CD11c, as well as 3) predisposed to induce fibrosis, evidenced by increased mRNA and protein expression of early profibrotic biomarker genes procollagen I and alpha-smooth muscle actin, and by increased collagen deposition. In cultured mouse and human hepatoma cells, EPS treatment induced oxidative stress, decreased cell viability, and triggered apoptosis evidenced by increased Caspase-3 cleavage/activation. In addition, EPS increased mRNA and protein expression of cytoglobin in mouse liver, indicating that EPS activated hepatic stellate cells (HSCs). Furthermore, EPS treatment in cultured human HSCs increased cell viability. In summary, EPS administration induced oxidative stress and inflammation in mouse liver, and stimulated liver fibrogenesis. Therefore, cautions should be exercised during EPS therapy.
Asunto(s)
Cirrosis Hepática Experimental/inducido químicamente , Hígado/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Rodanina/análogos & derivados , Tiazolidinas/toxicidad , Actinas/genética , Animales , Antígenos CD11/genética , Técnicas de Cultivo de Célula , Línea Celular Tumoral , Colágeno Tipo I/genética , Humanos , Inflamación , Hígado/inmunología , Hígado/metabolismo , Hígado/patología , Cirrosis Hepática Experimental/inmunología , Masculino , Ratones , Ratones Endogámicos C57BL , Rodanina/toxicidad , Factor de Necrosis Tumoral alfa/genéticaRESUMEN
The present study assessed the biological potential of fourteen 1,3-thiazolidin-4-ones evaluating the antiglioma effect through decreasing of cell viability of glioblastoma multiform cells. The new compounds were efficient synthesized through multicomponent or multicomponent one-pot procedures in moderate to good yields (22-86%) from two arenealdehydes (4-(methylthio)benzaldehyde and 4-(methylsulfonyl)benzaldehyde), seven amines (aromatic and aliphatic) and mercaptoacetic acid. The compounds were identified and characterized by GC/MS and NMR, five of them by HRMS. Six thiazolidinones showed significant effect of decreasing cell viability compared to standard drug TMZ at 100 µM in 72 h in C6 cell line by MTT assay. The compounds 5b, 5e, 5g and 6e showed the best results in the screening at 100 µM and were analyzed at different concentrations (5, 25, 50, 100 and 250 µM). Compounds 5b and 5e showed statistical difference at 5 µM, 6e at 25 µM and 5g at 50 µM in 72 h of treatment. The cytotoxicity study in primary astrocytes cells was evaluated and none of fourteen compounds showed toxicity at 100 µM, eight of them were not cytotoxic at 250 µM, both in 72 h. In addition, the propidium iodide assay demonstrated that the compounds might induce cell death by necrosis. In conclusion, this work reports at least four compounds (5b, 5e, 5g and 6e) with potential anti-tumor effect against glioblastoma multiform cell presenting activity at low concentrations and safe profile of cytotoxicity.
Asunto(s)
Benzaldehídos/síntesis química , Benzaldehídos/farmacología , Astrocitos/efectos de los fármacos , Benzaldehídos/química , Benzaldehídos/toxicidad , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Ensayos de Selección de Medicamentos Antitumorales , Glioma/tratamiento farmacológico , Humanos , Tiazolidinas/síntesis química , Tiazolidinas/química , Tiazolidinas/farmacología , Tiazolidinas/toxicidadRESUMEN
In this study, we designed and synthesized a series of thiophen-2-iminothiazolidine derivatives from thiophen-2-thioureic with good anti-Trypanosoma cruzi activity. Several of the final compounds displayed remarkable trypanocidal activity. The ability of the new compounds to inhibit the activity of the enzyme cruzain, the major cysteine protease of T. cruzi, was also explored. The compounds 3b, 4b, 8b and 8c were the most active derivatives against amastigote form, with significant IC50 values between 9.7 and 6.03µM. The 8c derivative showed the highest potency against cruzain (IC50=2.4µM). Molecular docking study showed that this compound can interact with subsites S1 and S2 simultaneously, and the negative values for the theoretical energy binding (Eb=-7.39kcal·mol(-1)) indicates interaction (via dipole-dipole) between the hybridized sulfur sp(3) atom at the thiazolidine ring and Gly66. Finally, the results suggest that the thiophen-2-iminothiazolidines synthesized are important lead compounds for the continuing battle against Chagas disease.
Asunto(s)
Tiazolidinas/farmacología , Tiofenos/farmacología , Tripanocidas/farmacología , Trypanosoma cruzi/efectos de los fármacos , Animales , Línea Celular , Cisteína Endopeptidasas , Inhibidores de Cisteína Proteinasa/síntesis química , Inhibidores de Cisteína Proteinasa/farmacología , Inhibidores de Cisteína Proteinasa/toxicidad , Glicina/química , Ratones , Simulación del Acoplamiento Molecular , Octoxinol , Proteínas Protozoarias/antagonistas & inhibidores , Tiazolidinas/síntesis química , Tiazolidinas/toxicidad , Tiofenos/síntesis química , Tiofenos/toxicidad , Tiourea/análogos & derivados , Tiourea/síntesis química , Tiourea/farmacología , Tiourea/toxicidad , Tripanocidas/síntesis química , Tripanocidas/toxicidadRESUMEN
Seven new 4-thiazolidinones bearing the morpholino moiety were easily synthesized by one-pot reactions of 4-(2-aminoethyl)morpholine (2-morpholinoethylamine), arenealdehydes and mercaptoacetic acid refluxing toluene for 19 h with moderate to good yields (45-97%). These novel compounds were fully identified and characterized by NMR spectroscopy and mass spectrometry. Thiazolidin-4-ones in vivo anti-inflammatory activities were determined using a croton oil-induced ear edema model of inflammation in BALB C mice. The best results were found for compounds 4c (49.20 mmol/kg), 4d (49.20 mmol/kg) and 4f (52.48 mmol/kg), which showed the ability to decrease the ear edema in mice by 50%, 48% and 54%, respectively, when compared to the standard drug indomethacin. In addition, the in vitro cytotoxicity activity of thiazolidin-4-ones against Vero cells was also performed and four compounds (4a, 4c, 4d and 4f) showed no toxic effect at 500 µg/mL. A docking simulation of compounds into the 1Q4G (COX-1) and 4PH9 (COX-2) enzymes binding site was conducted. This preliminary result will guide us in for further studies to improve the anti-inflammatory activity.
Asunto(s)
Antiinflamatorios no Esteroideos/síntesis química , Antiinflamatorios no Esteroideos/farmacología , Simulación del Acoplamiento Molecular , Tiazolidinas/síntesis química , Tiazolidinas/farmacología , Animales , Antiinflamatorios no Esteroideos/metabolismo , Antiinflamatorios no Esteroideos/toxicidad , Chlorocebus aethiops , Ciclooxigenasa 1/química , Ciclooxigenasa 1/metabolismo , Ciclooxigenasa 2/química , Ciclooxigenasa 2/metabolismo , Ratones , Conformación Proteica , Tiazolidinas/metabolismo , Tiazolidinas/toxicidad , Células VeroRESUMEN
ALC67 is an N-acylated thiazolidine compound with promising anticancer activity that led to the recent discovery of a series of 3-propionyl thiazolidine-4-carboxylic acid ethyl esters as a family of novel antiproliferative agents. Since the mutagenic and genotoxic properties of marketed anticancer molecules constitute a main issue to be addressed, this study focused on the analysis of the mutagenicity, antimutagenecity, and genotoxicity of this molecule. The mutagenicity and antimutagenicity of ALC67 were evaluated by Ames test performed on Salmonella TA98 and TA100 strains. The genotoxicity of this molecule was investigated in the chromosomal aberration assay on human lymphocytes. All results revealed that the analyzed structure is not mutagenic in the two Salmonella strains tested and was not genotoxic in human lymphocytes in vitro On the other hand, it showed a weak antimutagenic effect in these two bacterial strains. The above results indicate that after performing some more mutagenicity assays using the other recommended strains, this compound can be safely used for the development of new structures exhibiting anticancer activities.